Încărcări by ntnquynhpro

Dexamethasone 12 Mg Versus 6 Mg for Patients With COVID-19 and Severe Hypoxia

Cytokine Response in SARS-CoV-2 Infection in the ElderlyCytokine Response in SARS-CoV-2 Infection in the Elderly

Definition and Validation of Serum Biomarkers for Optimal Differentiation of Hyperferritinaemic Cytokine Storm Conditions in Children- A Retrospective Cohort Study

Definition and Validation of Serum Biomarkers for Optimal Differentiation of Hyperferritinaemic Cytokine Storm Conditions in Children- A Retrospective Cohort Study

Cytokine Response in SARS-CoV-2 Infection in the ElderlyCytokine Response in SARS-CoV-2 Infection in the Elderly

Dexamethasone 12 mg versus 6 mg for patients with COVID-19 and severe hypoxia

Antibiotics 09 00485

Ongoing Living Update of COVID-19 Therapeutic Options

Candiduria

Confusing Vocab

Common Uropathogens and Their Antibiotic Susceptibility Pattern Among Diabetic Patients

Bloodstream Infections in Hospitalized Adultswith Dengue Fever

The PERT Concept Q1 a Step-By-Step Approach to Managing Pulmonary Embolism

The Right Ventricle- Interaction With the Pulmonary Circulation

Spontaneous Awakening and Breathing Trials

The Septic Heart Current Understanding of Molecular Mechanisms and Clinical Implications

Ventilation Management in Acute Respiratory Failure Related to COVID-19 Versus ARDS From Another Origin – a Descriptive Narrative Review

Transfusion Strategies in Bleeding Critically Ill Adults- A Clinical Practice Guideline From the European Society of Intensive Care Medicine

Ventilator-Associated Pneumonia Caused by Multidrug-resistant Gram-negative Bacteria- Understanding Nebulization of Aminoglycosides and Colistin

Treatment Options for K. Pneumoniae, P. Aeruginosa and a. Baumannii Co‑Resistant to Carbapenems, Aminoglycosides, Polymyxins and Tigecycline- An Approach Based on the Mechanisms of Resistance to Carbapenems

Treatment Options for Carbapenem-resistant Gramnegative Bacterial Infections

Randomized Controlled Multicentre Study of Albumin Replacement Therapy in Septic Shock (ARISS)

Refractory Septic Shock

Autonomic Dysfunction in the Neurological ICU

10 Hoi Chung Trong Than Hoc

Surviving Sepsis Campaign- International Guidelines for Management of Sepsis and Septic Shock 2021

Pneumonia

Surviving Sepsis Campaign International.21

Treatment Options for K. Pneumoniae, P. Aeruginosa and a. Baumannii Co‑Resistant to Carbapenems, Aminoglycosides, Polymyxins and Tigecycline- An Approach Based on the Mechanisms of Resistance to Carbapenems

Treatment Options for Carbapenem-resistant Gramnegative Bacterial Infections

aln.0000000000004002

10.3389@fpubh.2019.00151

Surviving Sepsis Campaign International Guidelines

The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)

Treatment of Bleeding Complications in Patients on Anticoagulant Therapy

Spontaneous Abdominal Hemorrhage- Causes, CT Findings, And Clinical Implications

Non-Alcoholic Fatty Liver Disease- Causes, Diagnosis, Cardiometabolic Consequences, And Treatment Strategies

Spontaneous Abdominal Hemorrhage- Causes, CT Findings, And Clinical Implications

Management and Prevention of Anemia (Acute Bleeding Excluded) in Adult Critical Care Patients

Secondary Causes of Nonalcoholic Fatty Liver Disease

Guidelines for the Acute Treatment of Cerebral Edema in Neurocritical Care Patients

Predicting Anticoagulant-related Bleeding in Patients With Venous Thromboembolism- A Clinically Oriented Review

How I Assess and Manage the Risk of Bleeding in Patients Treated for Venous Thromboembolism

A Comparison of Sepsis-2 (Systemic Inflammatory Response Syndrome Based) to Sepsis-3 (Sequential Organ Failure Assessment Based) Definitions—a Multicenter Retrospective Study

Anemia in Intensive Care- A Review of Current Concepts

Changing Definitions of Sepsis

Anaemia During Critical Illness

Dear Sepsis-3, We Are Sorry to Say That We Don’t Like You*

The Research Methods Knowledge Base